Dividend7 May 2026, 10:41 pm
Shukra Pharma: Final Dividend Declared, Preferential Warrants Allotted
AI Summary
Shukra Pharmaceuticals Ltd. announced audited financial results for the quarter ended March 31, 2026. The Board recommended a final dividend of ₹0.01 (1%) per equity share for FY26, subject to shareholder approval. Additionally, the board approved the allotment of 17,35,000 fully paid-up equity shares to Dakshesh Shah and Parshva Texchem India Private Limited upon conversion of warrants, increasing the paid-up equity capital to ₹43,96,14,440.
Key Highlights
- Final dividend of ₹0.01 per share recommended for FY26.
- 17,35,000 equity shares allotted via warrant conversion.
- Paid-up equity capital increased to ₹43,96,14,440 after allotment.
- 29,08,000 warrants remain outstanding for conversion.
- Audited financial results for quarter and year ended March 31, 2026 approved.
Price Impact
More from SHUKRAPHAR